Copyright
©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 502-518
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.502
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.502
Figure 6 Jianpi Gushen Huayu Decoction inhibited c-Jun N-terminal kinase/P38 pathway mediated apoptosis and improved kidney injury.
A: TUNEL staining; B: Percentage of positive cells in TUNEL staining; C: Western blotting results; D: p-c-Jun N-terminal kinase (JNK)/JNK level; E: p-P38/P38 levels; F: Cleaved-caspase-3/caspase-3 levels; G: Cleaved caspase-9/caspase-9 levels. bP < 0.01 as compared to the control group; cP < 0.05 as compared to the model group; dP < 0.01 as compared to the model group. JPGSH: High-dose Jianpi Gushen Huayu Decoction; JNK: c-Jun N-terminal kinase.
- Citation: Ma ZA, Wang LX, Zhang H, Li HZ, Dong L, Wang QH, Wang YS, Pan BC, Zhang SF, Cui HT, Lv SQ. Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways. World J Diabetes 2024; 15(3): 502-518
- URL: https://www.wjgnet.com/1948-9358/full/v15/i3/502.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i3.502